MissionIR Articles

  • Rare Element Resources (REE) Presents at Rodman & Renshaw Conference

    Rare Element Resources Ltd. (NYSE: REE) is a strategic materials company focused on delivering rare earth products for technology and defense applications by advancing its Bear Lodge project in northeast Wyoming. Bear Lodge is a…

  • Radcom (RDCM) Presents at Rodman & Renshaw Conference

    RADCOM Ltd. (NASDAQ: RDCM) provides innovative service assurance and customer experience management solutions for leading telecom operators and communications service providers. The company specializes in solutions for next-generation mobile and fixed networks – including LTE,…

  • Quantum Materials (QTMM) Presents at Rodman & Renshaw Conference

    Quantum Materials Corp. (OTCBB: QTMM) develops and manufactures Quantum Dots and nanomaterials for use in display, lighting, medical and solar energy through its patented continuous-flow production process. Quantum Materials’ products are the foundation for technologically…

  • Pure Bioscience (PURE) Presents at Rodman & Renshaw Conference

    Pure Bioscience, Inc. (OTCQB: PURE) is focused on developing and commercializing its proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. Its technology platform is based on…

  • Pulmatrix (PULM) Presents at Rodman & Renshaw Conference

    Pulmatrix, Inc. (NASDAQ: PULM) is developing innovative inhaled therapies to address serious pulmonary disease using its clinically validated, proprietary iSPERSE technology. Leveraging the unique capabilities of iSPERSE to dramatically advance inhalation technology, the company means…

  • Protalex (PRTX) Presents at Rodman & Renshaw Conference

    Protalex, Inc. (OTCBB: PRTX) is a biotechnology company developing a new class of drugs with the potential to revolutionize the treatment of autoimmune and inflammatory diseases, including Rheumatoid Arthritis (RA) and Immune Thrombocytopenia (ITP). Protalex’s…

  • Prima BioMed (PBMD) Presents at Rodman & Renshaw Conference

    Prima BioMed Ltd. (NASDAQ: PBMD) is a globally active biotechnology company that is striving to become a leader in the development of immunotherapeutic products for the treatment of cancer. Prima BioMed is dedicated to leveraging…

  • Pretium Resources (PVG) Presents at Rodman & Renshaw Conference

    Pretium Resources, Inc. (NYSE: PVG) is advancing the high-grade gold Brucejack Project to production. The company is creating value through gold at its 100%-owned, advanced-stage Brucejack Project, which is located 65 kilometers north of the…

  • PolyMet Mining (PLM) Presents at Rodman & Renshaw Conference

    PolyMet Mining Corp. (NYSE: PLM) is a mine development company focused on permitting, building and operating the NorthMet copper-nickel-precious metals project through its wholly owned subsidiary, Poly Met Mining, Inc., a Minnesota corporation. Through long-term…

  • Pointer Telocation (PNTR) Presents at Rodman & Renshaw Conference

    Pointer Telocation Ltd. (NASDAQ: PNTR) is a leading provider of cutting-edge products and technology, and Software as a Service (SaaS) to the fleet, automotive, insurance, cargo and public-safety industries. Pointer Telocation has a growing client…

  • Plug Power (PLUG) Presents at Rodman & Renshaw Conference

    Plug Power, Inc. (NASDAQ: PLUG)aims to revolutionize the fuel cell industry with cost-effective solutions that increase productivity, lower operating costs and reduce carbon footprint. Its signature solution, GenKey, provides an all-inclusive package for customers, incorporating…

  • Pieris Pharmaceuticals (PIRS) Presents at Rodman & Renshaw Conference

    Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is a clinical-stage biotechnology company applying its proprietary Anticalin technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a…

  • Pershing Gold (PGLC) Presents at Rodman & Renshaw Conference

    Pershing Gold Corporation (OTCQB: PGLC) is an emerging Nevada gold producer uniquely positioned to create shareholder value by fast-track reopening of the Relief Canyon Mine. The company’s strategy to create shareholder value has four elements:…

  • Perseon (PRSN) Presents at Rodman & Renshaw Conference

    Perseon Corporation (NASDAQ: PRSN)is singularly focused on fighting one of humanity’s worst diseases, cancer, and on helping physicians and their patients fight cancer with technology. The company is dedicated to developing innovative technologies to fight…

  • Perma-Fix Environmental Services (PESI) Presents at Rodman & Renshaw Conference

    Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) is a nuclear services company and provider of nuclear and mixed waste management services. The company’s nuclear waste services include management and treatment of radioactive and mixed waste for…

  • PCM (PCMI) Presents at Rodman & Renshaw Conference

    Since 1987, PCM, Inc. (NASDAQ: PCMI) has provided IT products, services and solutions to businesses, government agencies, educational, institutions and healthcare facilities. The company provides access to more than 300,000 IT products like tablets, slate,…

  • EDAP TMS S.A (EDAP) Presents at Rodman & Renshaw Conference

    EDAP TMS S.A. (NASDAQ: EDAP) is a global leader in therapeutic ultrasound that has been present in the market for more than 35 years. The company develops, manufactures, promotes and distributes minimally-invasive medical devices for…

  • PAR Technology (PAR) Presents at Rodman & Renshaw Conference

    PAR Technology Corp. (NYSE: PAR)offers technology solutions for the full spectrum of restaurant operations, from large chain and independent table service restaurants to international quick service chains. PAR’s Hospitality business also markets hotel management systems…

  • OXIS International (OXIS) Presents at Rodman & Renshaw Conference

    OXIS International, Inc. (OTC: OXIS)develops innovative drugs focused on the treatment of cancer and other unmet medical needs.  OXIS’ lead drug candidate, DT2219ARL, is a novel bispecific scFv recombinant fusion protein-drug that simultaneously targets cancer…

  • OvaScience (OVAS) Presents at Rodman & Renshaw Conference

    OvaScience, Inc. (NASDAQ: OVAS) is a global fertility company; each OvaScience treatment is based on the company’s proprietary technology platform that leverages the breakthrough discovery of egg precursor (EggPCSM) cells – immature egg cells found…